HSP stock was spun off from drug stock Abbott Laboratories (NYSE: ABT ) and makes specialty injectable pharmaceuticals (primarily generics) and other drug delivery-related equipment. In fact, I believe the "euro crisis" centered in Greece and China's recent inflationary boom both present more benefits than challenges for investors, at least in the longer term. This recession-proof business hasn't missed a beat in the last year and has recently gained even more momentum due to health care reform measures that would broaden drug coverage.